Bayer proposes higher-than-expected dividend; J&J takes $100M charge on Venezuelan currency;

@FiercePharma: Teva UK pulls batches of generic Clarinex on impurities in tablets. More | Follow @FiercePharma

@EricPFierce: Capsule maker Qualicaps expanding in NC as it transitions to new ownership. News | Follow @EricPFierce

@AlisonBFierce: Dynavax will shoot for a limited approval of hep B vaccine Heplisav. The FDA nixed the product over safety issues. Report | Follow @AlisonBFierce

> Bayer plans a dividend of €1.90 ($2.51) per share, higher than the €1.82 ($2.38) expected by analysts. Report

> Johnson & Johnson ($JNJ) will take a $100 million charge against first-quarter profits because of Venezuela's currency devaluation. Report

> Amarin ($AMRN) asked the FDA to approve a new use for its blood-lipid treatment Vascepa, derived from fish oil. Release

> Fresenius Kabi's injectable drugs business is giving its parent company a boost; Fresenius SE expects 2013 profits to top €1 billion ($1.31 billion) on the unit's growth. Report

> Nestlé's health science unit bought the "medical foods" firm Pamlab, which makes products for patients with conditions such as diabetes, dementia and depression. Report

> Chemerix tapped former Glaxo Holdings CEO Ernest Mario to be chairman of the board. Report

> Mylan ($MYL) launched its version of AbbVie's ($ABBV) Tricor, a cholesterol fighter known generically as fenofibrate. Report

Medical Device News

 @FierceMedDev: NeuroPace wins FDA panel vote for epilepsy implant. More | Follow @FierceMedDev

 @MarkHFierce: A blood Dx to determine suicide risk? It's possible, and researchers will have a test ready for trials in a year. Story | Follow @MarkHFierce

 @DamianFierce: J&J has to fork over $3.4M in its first vaginal mesh verdict. Roughly 2,100 more lawsuits to go. Report | Follow @DamianFierce

> Abbott lops off another 450 jobs at stent plant. Article

> Mindray milestone: $1B in revenue in 2012. Item

> TearScience wins $70M funding commitment for dry eye device. Story

Biotech News

 @FierceBiotech: AstraZeneca claims PhIII sweep for OIC drug as CV concerns linger. News | Follow @FierceBiotech

@JohnCFierce: Officials prepare to dismantle patent rules that stifle drug R&D. Report | Follow @JohnCFierce

@RyanMFierce: Miami biotech Brickell revealed $7M B round for dermatology drug development. Florida a good spot for this company? Release | Follow @RyanMFierce

> Sanofi's Zerhouni, analysts warn sequestration could cripple R&D. Article

> Cosmetics group leads $7M round for dermatology upstart Brickell. Story

Biotech Research News

@EmilyMFierce: Retargeted bird virus could provide new treatment for prostate cancer. News | Follow @EmilyMFierce

> Therapeutic could heal wounds faster. Story

> New drug combo stops head and neck cancer in mice. Report

> Facebook, Google founders award $33M to life scientists. Item

> Obama administration plans brain-mapping project. More

Pharma Manufacturing News

> Teva repeats recall after getting batch numbers wrong. More

> Affymax explores manufacturing for ties to fatal drug reactions. Story

> Qualicaps expanding plant as Mitsubishi takes ownership. News

> Manufacturing continues to undercut Ranbaxy. Article

And Finally... Just one week of poor sleep can cause genetic changes that might lead to disease. Report